Abstract B028: Claudin-18 expression (using the 43-14A antibody kit) in pancreatic ductal adenocarcinoma: Assessment of a potential clinical biomarker for immunotherapy with zolbetuximab
Riley J. Arseneau(Dalhousie University), Thomas Arnason(Dalhousie University), Emma Kempster(Nova Scotia Health Authority), Jeanette E. Boudreau(Dalhousie University), Boris Gala-López(Dalhousie University), Carley Bekkers(Nova Scotia Health Authority), Ravi Ramjeesingh(Queen Elizabeth II Health Sciences Centre)
Cited by 0
Related Papers
Accuracy of coding for possible warfarin complications in hospital discharge abstracts
|Thrombosis Research|2005|194
Safety and Feasibility of Using Magnetic Resonance Imaging Criteria to Identify Patients With “Good Prognosis” Rectal Cancer Eligible for Primary Surgery
|JAMA Oncology|2019|117
Esophageal-guided biopsy with volumetric laser endomicroscopy and laser cautery marking: a pilot clinical study
|Gastrointestinal Endoscopy|2014|106
Collagenous gastritis: a morphologic and immunohistochemical study of 40 patients
|Modern Pathology|2014|101
Significance of Proximal Margin Involvement in Low-Grade Appendiceal Mucinous Neoplasms
|Archives of Pathology & Laboratory Medicine|2014|101